Compare ARK Genomic Revolution ETF (ARKG) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares International Treasury Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.55, while iShares International Treasury Bond ETF trades at $40.59. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | IGOV | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $43.09 |
52-Week Low | $23.09 | $40.54 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IGOV trades at $40.84, up 0.22% for the day, but technical indicators signal a bearish trend with moving averages and ADX pointing downward. The stock lacks key valuation and profitability metrics, indicating limited fundamental data availability. Recent news highlights downside risks from global inflationary pressures and high duration exposure in its bond holdings.
The outlook remains cautious due to macroeconomic headwinds and weak technical momentum. Investment opportunities are constrained by absent financial disclosures, while risks include interest rate sensitivity and geopolitical tensions. Investors should await clearer fundamental performance before considering positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
